Bio-Rad Laboratories Class A
317 hedge funds and large institutions have $4.83B invested in Bio-Rad Laboratories Class A in 2018 Q1 according to their latest regulatory filings, with 46 funds opening new positions, 97 increasing their positions, 120 reducing their positions, and 27 closing their positions.
70% more first-time investments, than exits
New positions opened: 46 | Existing positions closed: 27
5% more capital invested
Capital invested by funds: $4.58B → $4.83B (+$243M)
5% more funds holding
Funds holding: 302 → 317 (+15)
0.38% more ownership
Funds ownership: 77.91% → 78.3% (+0.38%)
19% less repeat investments, than reductions
Existing positions increased: 97 | Existing positions reduced: 120
29% less funds holding in top 10
Funds holding in top 10: 7 → 5 (-2)
38% less call options, than puts
Call options by funds: $3.08M | Put options by funds: $4.98M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
ClearBridge Investments
New York
|
+$32.1M |
| 2 |
Assenagon Asset Management
Senningerberg,
Luxembourg
|
+$30.8M |
| 3 |
American Century Companies
Kansas City,
Missouri
|
+$27.7M |
| 4 |
Point72 Asset Management
Stamford,
Connecticut
|
+$27.5M |
| 5 |
HM
HealthCor Management
New York
|
+$26.2M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
HCM
Hitchwood Capital Management
New York
|
-$68.7M |
| 2 |
Citadel Advisors
Miami,
Florida
|
-$45.4M |
| 3 |
PI
Putnam Investments
Boston,
Massachusetts
|
-$27.5M |
| 4 |
SEI Investments
Oaks,
Pennsylvania
|
-$21.9M |
| 5 |
UBS AM
Chicago,
Illinois
|
-$20.1M |
BIO Hedge Fund Activity: Q1 2018 in Review
317 of the 4,373 institutional investors tracked by Wall St. Rank reported a position in Bio-Rad Laboratories Class A (BIO) for Q1 2018, worth a combined $4.83B — up 5.3% from $4.58B a quarter earlier.
Buyers outnumbered sellers: 46 funds opened new BIO positions and 27 closed out — a net gain of 19 holders — while 97 added to existing stakes and 120 trimmed.
The largest buyer was ClearBridge Investments, opening a new position worth an estimated $32.1M. The largest seller was Hitchwood Capital Management, cutting an estimated $68.7M.
- 317 institutional investors held Bio-Rad Laboratories Class A (BIO) as of Q1 2018, up from 302 in Q4 2017.
- Funds reported $4.83B of Bio-Rad Laboratories Class A stock for Q1 2018, up 5.3% quarter-over-quarter.
- 46 funds opened new Bio-Rad Laboratories Class A positions in Q1 2018 and 27 closed out, a net change of +19 holders.
- The largest Bio-Rad Laboratories Class A buyer in Q1 2018 was ClearBridge Investments, an estimated $32.1M added.
- The largest Bio-Rad Laboratories Class A seller in Q1 2018 was Hitchwood Capital Management, an estimated $68.7M sold.
Based on aggregated 13F filings for Q1 2018.